Your browser doesn't support javascript.
loading
Association of unbalanced translocation der(1;7) with germline GATA2 mutations.
Kozyra, Emilia J; Göhring, Gudrun; Hickstein, Dennis D; Calvo, Katherine R; DiNardo, Courtney D; Dworzak, Michael; de Haas, Valerie; Starý, Jan; Hasle, Henrik; Shimamura, Akiko; Fleming, Mark D; Inaba, Hiroto; Lewis, Sara; Hsu, Amy P; Holland, Steven M; Arnold, Danielle E; Mecucci, Cristina; Keel, Siobán B; Bertuch, Alison A; Tawana, Kiran; Barzilai, Shlomit; Hirabayashi, Shinsuke; Onozawa, Masahiro; Lei, Shaohua; Alaiz, Helena; Andrikovics, Hajnalka; Betts, David; Beverloo, Berna H; Buechner, Jochen; Cermák, Martin; Cervera, José; Haus, Olga; Jahnukainen, Kirsi; Manola, Kalliopi N; Nebral, Karin; Pasquali, Francesco; Tchinda, Joelle; Turkiewicz, Dominik; Van Roy, Nadine; Zemanova, Zuzana; Pastor, Victor B; Strahm, Brigitte; Noellke, Peter; Niemeyer, Charlotte M; Schlegelberger, Brigitte; Yoshimi, Ayami; Wlodarski, Marcin W.
Afiliação
  • Kozyra EJ; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and.
  • Göhring G; Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Hickstein DD; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Calvo KR; Immune Deficiency-Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • DiNardo CD; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Dworzak M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
  • de Haas V; St. Anna Childrens Hospital and Cancer Research Institute, Pediatric Clinic, Medical University of Vienna, Vienna, Austria.
  • Starý J; Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands.
  • Hasle H; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Shimamura A; Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark.
  • Fleming MD; Dana-Farber and Boston Children's Cancer and Blood Disorders Center, Boston, MA.
  • Inaba H; Department of Pathology, Boston Children's Hospital, Boston, MA.
  • Lewis S; Department of Oncology and.
  • Hsu AP; Department of Hematology, St Jude Children's Research Hospital, Memphis, TN.
  • Holland SM; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Arnold DE; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Mecucci C; Immune Deficiency-Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Keel SB; Department of Medicine, Hematology and Bone Marrow Transplantation Unit, University of Perugia, Perugia, Italy.
  • Bertuch AA; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA.
  • Tawana K; Department of Pediatrics/Hematology-Oncology, Baylor College of Medicine, Houston, TX.
  • Barzilai S; Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Hirabayashi S; Pediatric Hematology and Oncology, Schneider Children's Medical Center of Israel, Petah-Tikva, Israel.
  • Onozawa M; Sackler Faculty of Medicine, Tel Aviv University, Israel.
  • Lei S; Department of Pediatrics and.
  • Alaiz H; Department of Hematology, Hokkaido University Faculty of Medicine, Graduate School of Medicine, Sapporo, Japan.
  • Andrikovics H; Department of Computational Biology, St Jude Children's Research Hospital, Memphis, TN.
  • Betts D; Hematology Department, Oncology Institute Francisco Gentil, Lisbon, Portugal.
  • Beverloo BH; Laboratory of Molecular Diagnostics, Central Hospital of Southern Pest, Budapest, Hungary.
  • Buechner J; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.
  • Cermák M; Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands.
  • Cervera J; Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Haus O; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
  • Jahnukainen K; Department of Genetics, The National Institute of Oncology, Bratislava, Slovakia.
  • Manola KN; Department of Hematology, Genetics Unit, Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Nebral K; Department of Clinical Genetics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
  • Pasquali F; New Children's Hospital, Pediatric Research Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Tchinda J; Department of Women's and Children's Health, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden.
  • Turkiewicz D; Department of Biodiagnostic Sciences and Technologies, The Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety (INRASTES), National Centre for Research 'Demokritos', Athens, Greece.
  • Van Roy N; Labdia Labordiagnostik GmbH, Clinical Genetics, Vienna, Austria.
  • Zemanova Z; Medical Genetics, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  • Pastor VB; Laboratory for Oncology, University Children's Hospital Zürich, Zürich, Switzerland.
  • Strahm B; Department of Pediatrics, Section of Pediatric Oncology, Hematology, Immunology and Nephrology, Skåne University Hospital, Lund, Sweden.
  • Noellke P; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Niemeyer CM; Center of Oncocytogenomics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine of Charles University, Prague, Czech Republic; and.
  • Schlegelberger B; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and.
  • Yoshimi A; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and.
  • Wlodarski MW; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and.
Blood ; 138(23): 2441-2445, 2021 12 09.
Article em En | MEDLINE | ID: mdl-34469508
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Mutação em Linhagem Germinativa / Fator de Transcrição GATA2 Tipo de estudo: Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Mutação em Linhagem Germinativa / Fator de Transcrição GATA2 Tipo de estudo: Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article